Doctor profile · Federal record
Dr. Jorge Oceguera, MD
Family Medicine Physician · Galt, CA
- NPI 1659384212
- 20 yrs on file
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
387 Civic Dr
Galt, CA 956322059
(209) 745-8080
Credentials & registration
- NPI registered
- August 2006 — 20 yrs on file
- Profile last updated
- July 8, 2007
- Specialty taxonomy
- 207Q00000X — NUCC code
- State license (1)
- California #A75542
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1659384212. Last verified May 11, 2026.Open Payments
Industry payments received
All-time total
$102
Transactions
5
Manufacturers
4
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Astellas Pharma US INC | 2 | $41.02 | |
| GlaxoSmithKline, LLC. | 1 | $24.63 | |
| Abbvie INC. | 1 | $18.86 | |
| Exact Sciences Corporation | 1 | $17.21 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
4,455
Patients
966
Total drug cost
$68,766
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Atorvastatin Calcium | Generic | 738 | 171 | $12,466 |
| Amlodipine Besylate | Generic | 463 | 101 | $5,597 |
| Metformin Hcl | Generic | 429 | 105 | $5,378 |
| Lisinopril | Generic | 388 | 88 | $5,104 |
| Levothyroxine Sodium | Generic | 325 | 58 | $5,861 |
| Hydrochlorothiazide | Generic | 308 | 61 | $1,432 |
| Omeprazole | Generic | 264 | 66 | $4,667 |
| Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen) | Brand | 255 | 31 | $5,103 |
| Losartan Potassium | Generic | 247 | 60 | $5,093 |
| Gabapentin | Generic | 233 | 46 | $5,754 |
Frequently asked questions
What is Dr. Jorge Oceguera's medical specialty?
Dr. Jorge Oceguera practices Family Medicine Physician in Galt, CA.
Where does Dr. Jorge Oceguera practice?
Dr. Jorge Oceguera practices at 387 Civic Dr, Galt, CA 956322059. Office phone: 2097458080.
What is Dr. Jorge Oceguera's NPI?
Dr. Jorge Oceguera's National Provider Identifier (NPI) is 1659384212, issued by NPPES.